Exelixis, Inc. (EXEL) Q1 2008 Earnings Results

Exelixis Inc Misses on EPS, Stock Down 0.89%

Exelixis Inc reported a loss per share of $0.39 but did not disclose revenue figures. The stock fell by 0.89% following the earnings report, reflecting investor uncertainty due to the lack of guidance and specific revenue details. The focus on clinical trials suggests that the company is prioritizing long-term growth over immediate financial performance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$-0.39	N/A	N/A
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Defensive

Management expressed a cautious approach, emphasizing the importance of their ongoing projects. They did not provide any updates on future guidance.

Management did not provide specific revenue figures or guidance for the upcoming quarters.

The focus remains on ongoing clinical trials and product development.

Exelixis Inc Misses on EPS, Stock Down 0.89%

Key numbers

Management commentary

Exelixis, Inc.

More earnings this week

Exelixis Inc Misses on EPS, Stock Down 0.89%

Key numbers

Management commentary